about
Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma.Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjectsTubulin isoforms identified in the brain by MALDI in-source decay.Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide.[AP-HM tumour tissue bank: molecular signature of gliomas].Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma.Adrenomedullin as a therapeutic target in angiogenesis.Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.Mammalian peptidylglycine alpha-amidating monooxygenase mRNA expression can be modulated by the La autoantigenPharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancerQuantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers.MALDI imaging and in-source decay for top-down characterization of glioblastoma.Detection of BRAF V600 mutations in melanoma: evaluation of concordance between the Cobas® 4800 BRAF V600 mutation test and the methods used in French National Cancer Institute (INCa) platforms in a real-life settingMonitoring therapeutic monoclonal antibodies in brain tumor.Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo.Endo/exo-proteolysis in neoplastic progression and metastasis.EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer.Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumorsStromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretionOTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models.Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.Correlates of HPV: a cross-sectional study in women with normal cytology in north-central Morocco.Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer.Adrenomedullin expression and regulation in human glioblastoma, cultured human glioblastoma cell lines and pilocytic astrocytoma.Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice.A2B5 cells from human glioblastoma have cancer stem cell properties.Adrenomedullin promotes cell cycle transit and up-regulates cyclin D1 protein level in human glioblastoma cells through the activation of c-Jun/JNK/AP-1 signal transduction pathway.Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).
P50
Q27852713-AF0849F5-9B41-41E7-B496-846D7E9F0131Q28394993-0443E938-DCF1-4EFE-9DE8-F19BDBDC669BQ31109952-970AB132-2BE0-4515-B682-8454DF6173A3Q33291100-89A5B7EA-FEC8-4D8A-95C9-0BBFCADB4523Q33374934-95DEAF95-589B-46C0-8502-48D32774B706Q33449474-75558BCF-2C6B-46AB-AE91-D5C98F20D0BBQ33483439-77EC6DC0-ED84-4BAB-9872-7A1331EA603DQ33693793-1A22555E-8190-4166-BFBA-4780AA21D20AQ33911224-10C383E8-337A-46F1-BACD-81CBAD551C4BQ33925150-332EB1A1-DE1F-4034-B072-0AF72EE68C4EQ34083752-248D0AD2-FD30-490E-8FF0-7F038E2D0599Q35029573-17FC0B73-31F6-4CE6-A202-86F9824BB1C5Q35077422-B3E51304-5EA3-4227-86D9-1352A4943E18Q35196177-9749ECF6-CBB2-47E4-AE1D-8DFC13BCEACFQ35498835-351D4139-1F89-4577-BB73-77B516367472Q35788931-6F330658-3C98-410C-BB6B-F5F3E134DCE3Q36245383-5A548FED-271D-41FA-A1D8-24DA3AB46F2EQ37534932-30B55935-1ECB-4CB8-AFAF-A3FA8D968812Q37709230-A6CB5984-FB02-4ABA-A609-8B8ABDF2B7B5Q37716611-1F685637-7C62-4EE2-BC61-BEEC6033DE91Q38759279-E93D56E3-9FA3-4592-A33D-BB13DCDDA8AAQ38804046-A8FD2489-0F38-4E8F-A832-C0AD59BAE253Q38903830-42CCA1AA-5AA0-4708-B861-E7BBDC3E4AB0Q38903834-8EB374D9-020E-444A-B65D-6415B6068DB3Q39565819-1B082644-98A6-4CFB-A947-8C4A9CC26C99Q39834681-ACA83BA6-36F1-460A-B884-6BB74841390EQ39879785-BE40EBB8-0AEF-43B4-B74F-0C6F37D3B9D5Q39891340-7AD6E8AC-51E5-416C-8B2F-3A45409DB43FQ40096915-60656F54-1117-4599-B4B2-E5EAC1222DD9
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
L'Houcine Ouafik
@ast
L'Houcine Ouafik
@en
L'Houcine Ouafik
@es
L'Houcine Ouafik
@sl
type
label
L'Houcine Ouafik
@ast
L'Houcine Ouafik
@en
L'Houcine Ouafik
@es
L'Houcine Ouafik
@sl
altLabel
L'houcine Ouafik
@en
prefLabel
L'Houcine Ouafik
@ast
L'Houcine Ouafik
@en
L'Houcine Ouafik
@es
L'Houcine Ouafik
@sl